CHINARES PHARMA (03320): China Resources Boya Bio-pharmaceutical Group's net profit for the first three quarters was RMB60.5883 million, a year-on-year decrease of 82.34%
China Resources Pharma (03320) announced that China Resources Boya Bio-pharmaceutical Group recorded total operating revenue of RMB847 million (same unit below) for the nine months ended September 30, 2026, a year-on-year decrease of 42.54%; net profit was RMB60.5883 million, a year-on-year decrease of 82.34%.
CHINARES PHARMA (03320) announced that China Resources Boya Bio-pharmaceutical Group recorded total operating revenue of RMB847 million (same unit below) for the nine months ended September 30, 2026, a year-on-year decrease of 42.54%; net profit was RMB60.5883 million, a year-on-year decrease of 82.34%.
Related Articles
UBOX ONLINE (02429) repurchased 2,000 shares on October 29 for HK$2,800.
DALIPAL HLDG (01921) repurchased 622,000 shares on October 29 for approximately HK$1.8419 million.
CGN POWER (01816): "26 CGN Power SCP001" and "26 CGN Power SCP002" will be redeemed on November 6.
UBOX ONLINE (02429) repurchased 2,000 shares on October 29 for HK$2,800.
DALIPAL HLDG (01921) repurchased 622,000 shares on October 29 for approximately HK$1.8419 million.
CGN POWER (01816): "26 CGN Power SCP001" and "26 CGN Power SCP002" will be redeemed on November 6.
